
How much is a share of NWBO worth?
One share of NWBO stock can currently be purchased for approximately $0.83. How much money does Northwest Biotherapeutics make? Northwest Biotherapeutics has a market capitalization of $785.58 million and generates $1.29 million in revenue each year.
How much has Northwest Biotherapeutics'(NWBO) stock increased since last quarter?
Since then, NWBO stock has increased by 360.8% and is now trading at $0.8290. View which stocks have been most impacted by COVID-19. How were Northwest Biotherapeutics' earnings last quarter? Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO) posted its quarterly earnings results on Monday, November, 15th.
Will Northwest Biotherapeutics (NWBO) outperform or underperform the S&P 500?
MarketBeat's community ratings are surveys of what our community members think about Northwest Biotherapeutics and other stocks. Vote “Outperform” if you believe NWBO will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NWBO will underperform the S&P 500 over the long term.
Why is NWBO going down?
That is why NWBO went down when the publication of interim results was released, why NWBO has gone down every time those results have been presented, and why no pharma or institutions have shown any interest in DCVax-L. Powers spends about 15 minutes a year with a few of her retail shareholders. Over 20 years plus… This is all that matters…

Is NWBO stock a good buy?
Northwest Biotherapeutics Inc (OTCQB:NWBO) The 1 analysts offering 12-month price forecasts for Northwest Biotherapeutics Inc have a median target of 15.10, with a high estimate of 15.10 and a low estimate of 15.10. The median estimate represents a +1,943.30% increase from the last price of 0.74.
Is NWBO an OTC stock?
NWBO | Northwest Biotherapeutics Inc. Stock Overview (U.S.: OTC) | Barron's.
How do I buy NWBO stock?
Shares of NWBO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Is NWBO on Nasdaq?
Northwest Biotherapeutics Inc (NWBO) Pre-Market Quotes | Nasdaq.
How many shares of Nwbo are there?
Share StatisticsAvg Vol (3 month) 34.48MShares Outstanding 5984.25MImplied Shares Outstanding 6N/AFloat 8953.14M% Held by Insiders 13.27%7 more rows
Is Anvs stock a good buy?
The consensus among 1 Wall Street analyst covering (NYSE: ANVS) stock is to Strong Buy ANVS stock.
0.0 Analyst's Opinion
How has Northwest Biotherapeutics' stock been impacted by COVID-19 (Coronavirus)?
Northwest Biotherapeutics has received 171 “outperform” votes. (Add your “outperform” vote.)
How were Northwest Biotherapeutics' earnings last quarter?
Northwest Biotherapeutics' stock was trading at $0.1799 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, NWBO stock has increased by 444.7% and is now trading at $0.98. View which stocks have been most impacted by COVID-19.
Who are some of Northwest Biotherapeutics' key competitors?
Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO) posted its quarterly earnings results on Monday, August, 10th. The biotechnology company reported ($0.54) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.32) by $0.22.
What other stocks do shareholders of Northwest Biotherapeutics own?
Some companies that are related to Northwest Biotherapeutics include Apellis Pharmaceuticals (APLS), Arvinas (ARVN), Cerevel Therapeutics (CERE), Karuna Therapeutics (KRTX), CureVac (CVAC), Prestige Consumer Healthcare (PBH), Cytokinetics (CYTK), Pacira BioSciences (PCRX), PTC Therapeutics (PTCT), Insmed (INSM), Corcept Therapeutics (CORT), Indivior (INVVY), Amicus Therapeutics (FOLD), Emergent BioSolutions (EBS) and Harmony Biosciences (HRMY). View all of NWBO's competitors..
What is Northwest Biotherapeutics' stock symbol?
Based on aggregate information from My MarketBeat watchlists, some companies that other Northwest Biotherapeutics investors own include Clearside Biomedical (CLSD), Ocular Therapeutix (OCUL), Melinta Therapeutics (MLNT), (ZLTQ) (ZLTQ), Avid Bioservices (CDMO), Idera Pharmaceuticals (IDRA), TransEnterix (TRXC), Amarin (AMRN), Inovio Pharmaceuticals (INO) and MEI Pharma (MEIP)..
How do I buy shares of Northwest Biotherapeutics?
Northwest Biotherapeutics trades on the OTCMKTS under the ticker symbol "NWBO."
When did Northwest conduct interim analysis?
Shares of NWBO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Is Linda Powers using the Healthbank trademark?
Northwest was supposed to conduct two interim analyses of the trial data starting in December 2013. Yes, you read that right, December of 2013. By August 2014, however, the company had released a statement claiming that "no interim analysis of efficacy in the Phase III trial [had] been done.".